Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Vitamin E Supplements, Lung Cancer Risk Needs Further Review - ATBC Study

This article was originally published in The Tan Sheet

Executive Summary

Further review of the effects of vitamin E supplementation on lung cancer risk among male smokers is recommended by Alpha-Tocopherol, Beta Carotene Cancer Prevention (ATBC) Study researchers in a report published in the Oct. 20 issue of the Journal of the National Cancer Institute.

You may also be interested in...

Smokers "should avoid high-dose beta carotene supplementation" -- new ATBC analysis.

HIGH-DOSE BETA CAROTENE SUPPLEMENTATION SHOULD BE AVOIDED BY SMOKERS, researchers from the Alpha-Tocopherol, Beta Carotene Cancer Prevention (ATBC) Study reported in the Nov. 6 issue of the Journal of the National Cancer Institute. The Finnish study, designed to test the assumption that beta carotene and vitamin E supplementation would reduce the incidence of lung cancer in smokers, found that the opposite was true: smokers taking beta carotene had a higher incidence of lung cancer than those who did not smoke.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts